推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Immunotherapy

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 IMMUNOTHERAPY-U最新评论:in peer review快4个月,好慢 (2023-12-25)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Immunotherapy期刊基本信息Hello,您是该期刊的第25509位访客


基本信息 登录收藏
期刊名字ImmunotherapyImmunotherapy

IMMUNOTHERAPY-UK
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.4
50人评分
我要评分

声誉
7.6

影响力
5.0

速度
8.5

期刊ISSN1750-743X
微信扫码收藏此期刊
E-ISSN1750-7448
2022-2023最新影响因子
(数据来源于搜索引擎)
2.8 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:2.537
2022-2023自引率3.60%点击查看自引率趋势图
五年影响因子3.2
h-index 37
CiteScore
CiteScoreSJRSNIPCiteScore排名
6.000.7980.600
学科分区排名百分位
大类:Medicine
小类:Oncology
Q2128 / 366
大类:Medicine
小类:Immunology and Allergy
Q293 / 211
大类:Medicine
小类:Immunology
Q3113 / 217

期刊简介
Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
期刊官方网站https://www.futuremedicine.com/loi/imt
期刊投稿网址https://mc04.manuscriptcentral.com/fm-imt
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Immunotherapy的语言要求,还能让Immunotherapy编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Immunotherapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
出版商Future Medicine Ltd.
涉及的研究方向医学-免疫学
出版国家或地区ENGLAND
出版语言English
出版周期Bimonthly
出版年份0
年文章数 101点击查看年文章数趋势图
Gold OA文章占比18.96%
研究类文章占比:
文章 ÷(文章 + 综述)
68.32%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:4区

按学科分区JIF分区JIF排名JIF百分位
学科:IMMUNOLOGY
类别:SCIE
Q4122/161
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区4区1区
IMMUNOLOGY
免疫学
3区3区4区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区3区
IMMUNOLOGY
免疫学
2区2区4区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区2区
IMMUNOLOGY
免疫学
3区4区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1750-743X%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Immunotherapy顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Immunotherapy期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Immunotherapy中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Immunotherapy上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE REVIEWS IMMUNOLOGY35183.00
    Immunity35557.70
    NATURE IMMUNOLOGY34441.00
    Annual Review of Immunology27954.10
    Cellular & Molecular Immunology6422.00
    TRENDS IN IMMUNOLOGY20927.90
    JOURNAL OF EXPERIMENTAL MEDICINE41124.10
    BRAIN BEHAVIOR AND IMMUNITY12724.30
    AUTOIMMUNITY REVIEWS10323.30
    JOURNAL OF AUTOIMMUNITY10124.90
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE609725
    BIOMATERIALS519611
    BIOMEDICINE & PHARMACOTHERAPY473086
    Journal of Materials Chemistry B464623
    Frontiers in Pharmacology457364
    Frontiers in Immunology429273
    JOURNAL OF ETHNOPHARMACOLOGY411928
    COLLOIDS AND SURFACES B-BIOINTERFACES407901
    Frontiers in Oncology389688
    Acta Biomaterialia380926
  •  

    Immunotherapy Immunotherapy
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Establishment of humanized mice and its application progress in cancer immunotherapy

    Author: Ding, Tianlong; Yu, Yang; Pan, Xiaoyuan; Chen, Hao
    Journal: IMMUNOTHERAPY. 2023; Vol. , Issue , pp. -. DOI: 10.2217/imt-2022-0148
        PubMed      DOI
    2.Coexpression of c-Jun in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapy

    Author: Xu, Tongpeng; Wang, Chen; Chen, Xiaomei; Bai, Jian; Wang, Enxiu; Sun, Ming
    Journal: IMMUNOTHERAPY. 2023; Vol. 14, Issue 18, pp. 1457-1466. DOI: 10.2217/imt-2022-0171
        PubMed      DOI
    3.Application of immune checkpoint inhibitors in immunotherapy for gastric cancer

    Author: Wu, Yi-Xiang; Zhou, Xiao-Yu; Wang, Jian-Qi; Chen, Gao-Min; Chen, Jin-Xu; Wang, Rong-Chang; Huang, Jiong-Qiang; Chen, Jing-Song
    Journal: IMMUNOTHERAPY. 2023; Vol. 15, Issue 2, pp. 101-115. DOI: 10.2217/imt-2022-0080
        PubMed      DOI
    4.A new perspective on the potential application of RIPK1 in the treatment of sepsis

    Author: Wang, Xuesong; Chai, Yan; Guo, Zhe; Wang, Ziyi; Liao, Haiyan; Wang, Ziwen; Wang, Zhong
    Journal: IMMUNOTHERAPY. 2022; Vol. 15, Issue 1, pp. 43-56. DOI: 10.2217/imt-2022-0219
        PubMed      DOI
    5.Sintilimab combined with chemotherapy successfully treated a patient with advanced submandibular gland tumor

    Author: Zhang, Yingfang; Zhang, Min; Zhang, Jing; Zhao, Kelei; Yuan, Xiaohan; Di, Wenyu; Liu, Yanting; Lu, Ping
    Journal: IMMUNOTHERAPY. 2023; Vol. 15, Issue 1, pp. 27-33. DOI: 10.2217/imt-2022-0130
        PubMed      DOI
    6.A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma

    Author: Cheng, Yajie; Ouyang, Wen; Jie, Chen; Zhang, Junhong; Yu, Jing; Xie, Conghua
    Journal: IMMUNOTHERAPY. 2023; Vol. 15, Issue 2, pp. 71-75. DOI: 10.2217/imt-2022-0018
        PubMed      DOI
    7.Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes

    Author: Zhang, Hui; Jiang, Da; Meng, Erhong; Zhao, Meng; Niu, Beifang
    Journal: IMMUNOTHERAPY. 2023; Vol. 15, Issue 1, pp. 17-25. DOI: 10.2217/imt-2021-0259
        PubMed      DOI
    8.Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient

    Author: Gao, Song; Wang, Jiaqian; Zhu, Zhongzheng; Fang, Juemin; Zhao, Yu; Liu, Zhuqing; Qin, Huanlong; Wei, Yuquan; Xu, Heng; Dan, Xu; Yang, Li; Xu, Qing
    Journal: IMMUNOTHERAPY. 2023; Vol. 15, Issue 2, pp. 57-70. DOI: 10.2217/imt-2021-0339
        PubMed      DOI
    9.Efficacy of PD-1/PD-L1 plus CTLA-4 inhibitors in solid tumors based on clinical characteristics: a meta-analysis

    Author: Huo, Gengwei; Liu, Wenjie; Zhang, Sipei; Chen, Peng
    Journal: IMMUNOTHERAPY. 2023; Vol. 15, Issue 3, pp. 189-207. DOI: 10.2217/imt-2022-0140
        PubMed      DOI
    10.FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinoma

    Author: Zhang, Jingtao; Li, Haitao; Guo, Minghao; Zhang, Jing; Zhang, Guangming; Sun, Ning; Feng, Yuyuan; Cui, Wenqiang; Xu, Fei
    Journal: IMMUNOTHERAPY. 2023; Vol. 15, Issue 4, pp. 235-252. DOI: 10.2217/imt-2022-0195
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    HARVARD BUSINESS REVIEW02.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.10
    Energy Material Advances08.50
    CLINICAL AND EXPERIMENTAL HYPERTENSION453.60
    Journal of Public Transportation07.00
    Asian Journal of Psychiatry010.90
    Chinese Journal of Population Resources and Environment02.60
    VIEW08.60
    HLA933.00
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY011.50


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共27条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451